Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.
Wendy Wing-Lok ChanCheuk-Wai ChoiIan Yu-Hong WongTerence Hon-Ting TsangAdrian Tin-Chung LamRosa Pui-Ying TseK K ChanClaudia WongBetty Tze-Ting LawEmina Edith CheungSiu-Yin ChanKa-On LamDora KwongSimon LawPublished in: Annals of surgical oncology (2022)
Induction DCF and subsequent conversion surgery offered a chance of cure with long-term survival benefit and manageable toxicities in patients with locoregionally advanced unresectable esophageal cancer.